Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 9,638 | 3,833 | 212,236 | 1,840 | 982 |
| Cost of Goods | 1,688 | 275 | 398 | 31 | N/A |
| Gross Profit | 7,941 | 3,558 | 211,847 | 1,809 | 982 |
| Operating Expenses | 104,207 | 84,384 | 83,066 | 76,286 | 59,946 |
| Operating Income | -95,569 | -80,551 | 129,170 | -74,446 | -58,964 |
| Interest Expense | 8,931 | 4,928 | 4,640 | 4,171 | 4,124 |
| Other Income | 24 | 42 | 81 | 368 | 1,142 |
| Pre-tax Income | -104,476 | -85,437 | 124,611 | -78,249 | -61,946 |
| Net Income Continuous | -104,476 | -85,437 | 124,611 | -78,249 | -61,946 |
| Net Income | $-104,476 | $-85,437 | $124,611 | $-78,249 | $-61,946 |
| EPS Basic Total Ops | -3.82 | -3.07 | 4.50 | -2.84 | -2.32 |
| EPS Basic Continuous Ops | -3.82 | -3.07 | 4.50 | -2.84 | -2.32 |
| EPS Diluted Total Ops | -3.64 | -3.07 | 4.32 | -2.84 | -2.13 |
| EPS Diluted Continuous Ops | -3.63 | -3.07 | 4.32 | -2.84 | -2.13 |
| EBITDA(a) | $-93,668 | $-80,392 | $129,268 | $-74,413 | $-58,923 |